K-numberK252334
Device namePELVIPOWER Pelvic Functional Magnetic Stimulation (PELVIPOWER PelvicFMS) (033-0-1100-02)
ApplicantPontemedag
Product codeKPI
Device classClass II
Decision dateApr 17, 2026
DecisionSubstantially Equivalent
Regulation876.5320
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The PELVIPOWER PelvicFMS is a non-invasive pelvic floor muscle stimulator that uses electromagnetic field impulses to strengthen and rehabilitate weak pelvic muscles and restore neuromuscular control. It is intended for treatment of male and female urinary incontinence and is delivered via an adjustable chair with a 12-inch touchscreen interface in healthcare facilities.

Technological characteristics

The subject device generates magnetic field intensity of 0.5–2 T at pulse repetition rates of 5–50 Hz with 340 µs pulse width, adjustable in 6 increments, with therapy sessions up to 22 minutes. The predicate generates 0.7–2.5 T at 1–150 Hz with 280 µs pulse width, adjustable 0–100%, with up to 30-minute sessions. The subject device includes a novel 150 mm horizontal coil adjustment feature absent in the predicate, and a smaller seat applicator (51×54 cm vs. 73×73 cm).

Test standards cited

Testing per IEC 60601-1:2020 (electrical safety), IEC 60601-1-2:2020 (electromagnetic compatibility), IEC 60601-4-2:2024 (EMC test guidance), FDA guidance on software verification/validation and cybersecurity, and ASTM F2182-19E02 for coil temperature rise.

Substantial equivalence argument

Both devices have the same intended use, function, energy type, stimulation source, and prescription-only status. Although the subject device has different technological characteristics (magnetic field intensity range, pulse parameters, therapy time, and novel coil adjustment), performance testing demonstrated these differences do not raise different questions of safety or effectiveness. The BTL-398 was used as reference for coil movement testing, and all acceptance criteria were met.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →